Tradewinds Capital Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Tradewinds Capital Management’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-35	Closed	-$1K	–	644
2019 Q2	$1K	Hold	35	–	–	﹤0.01%	580
2019 Q1	$1K	Sell	35 -100	-74%	-$3.34K	﹤0.01%	582
2018 Q4	$4K	Hold	135	–	–	﹤0.01%	498
2018 Q3	$5K	Buy	+135	New	+$5.12K	﹤0.01%	502
2016 Q4	–	Sell	-100	Closed	-$3K	–	686
2016 Q3	$3K	Hold	100	–	–	﹤0.01%	503
2016 Q2	$2K	Buy	+100	New	+$2.38K	﹤0.01%	565

Other funds holding SBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

Cambridge Trust Cambridge, Massachusetts $2.64B AUM 28.73% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

WIA

Wealthstreet Investment Advisors Dallas, Texas $3.71M AUM 13.1% 1-Year Est. Return

Tradewinds Capital Management's SBIO Position: Q3 2019 in Review

Tradewinds Capital Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2019, closing a stake of 35 shares — an estimated $1K sold.

Tradewinds Capital Management first reported a position in SBIO in Q2 2016 and held it in 6 quarters. The position peaked at $5K in Q3 2018. 47 funds tracked by Wall St. Rank hold SBIO as of Q3 2019.

Tradewinds Capital Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2019 after selling out during the quarter.
Tradewinds Capital Management sold 35 ALPS Medical Breakthroughs ETF shares in Q3 2019, an estimated $1K.
Tradewinds Capital Management first reported a position in ALPS Medical Breakthroughs ETF in Q2 2016 and held it in 6 quarters.
Tradewinds Capital Management's ALPS Medical Breakthroughs ETF position peaked at $5K in Q3 2018.
47 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2019.

Based on Tradewinds Capital Management's 13F filing for Q3 2019, filed 17 Oct 2019.